SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001718108-22-000015
Filing Date
2022-05-09
Accepted
2022-05-09 07:09:13
Documents
64
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q surf-20220331.htm   iXBRL 10-Q 1061608
2 EX-31.1 surf-03312022xexx311.htm EX-31.1 10211
3 EX-31.2 surf-03312022xexx312.htm EX-31.2 10011
4 EX-32.1 surf-03312022xexx321.htm EX-32.1 5146
5 EX-32.2 surf-03312022xexx322.htm EX-32.2 4854
  Complete submission text file 0001718108-22-000015.txt   5898380

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT surf-20220331.xsd EX-101.SCH 42254
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT surf-20220331_cal.xml EX-101.CAL 58101
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT surf-20220331_def.xml EX-101.DEF 252644
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT surf-20220331_lab.xml EX-101.LAB 577727
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT surf-20220331_pre.xml EX-101.PRE 392077
58 EXTRACTED XBRL INSTANCE DOCUMENT surf-20220331_htm.xml XML 863903
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38459 | Film No.: 22903223
SIC: 2836 Biological Products, (No Diagnostic Substances)